Cell Isolation Market Research Report Information By Cell Type (Human Cells and Animal Cells), By Techniques (Centrifugation, Surface Marker, and Filtration), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2034

Global Cell Isolation Market Overview

As per MRFR analysis, the Cell Isolation Market Size was estimated at 6.80 (USD Billion) in 2024. The Cell Isolation Market Industry is expected to grow from 8.01 (USD Billion) in 2025 to 34.98 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 17.80% during the forecast period (2025 - 2034). Increased adoption of cell isolation techniques and rising cases of chronic diseases with a growing geriatric population ly are the key market drivers enhancing the growth of market. 

Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review

It was in May 2023 when Beckman Coulter launched a new kind of advanced immunoassay analyzer called DxI 9000 Access. The analyzer is able to run up to 215 tests per hour per square meter (t/h/m2). For this, Alfa Laval AB has decided on an investment program that implies a capacity expansion project with regard to heat exchangers worth SEK 3.8 billion ($360 million) by February 2023. Alfa Laval is expanding its production capacity for heat exchangers across Sweden, Italy, China and the USA as part of a larger investment program.For example, Thermo Fisher Scientific launched the new fully-customizable Gibco CTS Xenon Electroporation System, bringing large-scale cell therapy development and clinical manufacturing in line with increasing demand. The Gibco CTS Xenon Electroporation System is a complementary addition to Thermo Fisher Scientific's end-to-end cell therapy solutions. Therefore, such innovations and product launches are likely to propel the growth of the Cell Isolation Market during the forecast period.Similarly, Applied Cells Inc. and STEMCELL Technologies announced their collaboration in April 2022 aimed at delivering a new high-performance cell separation solution that combines Applied Cells' MARS platform with STEMCELL's EasySep immunomagnetic cell separation kits. This will enable global researchers to automate the isolation process and improve efficiency when handling different sample types, including whole blood, bone marrow, apheresis products, and dissociated tissue. Additionally, STEMCELL’s Cell Isolation reagents will expand on the applicability of the MARS platform by meeting specialized requirements for isolating very rare cancer cells from human samples. Thus, factors such as initiatives by key market players are expected to boost the segment’s growth.In October 2022, Thermo Fisher Scientific launched a closed and automated cell isolation and bead removal solution to help evolve cell therapy manufacturing. The cell purity, isolation efficiency, and target cell recovery for scalable cell therapy manufacturing have improved with the new technology.Sony Corporation unveiled CGX10, an advanced cell isolation system that sorts cells at high speed and high purity in a closed system, in January 2022.

Cell Isolation Market Trends

• The growing adoption of cell separation techniques is driving the market growth.

Market CAGR for cell isolation is being driven by the rising adoption of cell separation techniques in the biotechnology and pharmaceutical industries, mainly in developing countries. The technique is well practiced for the development of regenerative medicine, boosting stem cell research. The growing prevalence of the chronic diseases and rising geriatric population is surging the demand for clinical trials and research. The rising productive partnerships in microfluidics are expected to fuel cell isolation technologies ly.

The growing number of chronic diseases like obesity, diabetes, arthritis, cancer, and cardiac diseases are rising owing to the sedentary lifestyle, aging of the  population, and growth in the consumption of alcohol and cigarette smoking. The geriatric population is anticipated to suffer from chronic diseases like neurological disorders and cancer more often compared to the younger population, and moreover, there is a rapid growth in the geriatric population. Hence, the geriatric population aged 65 years and above is anticipated to increase the incidence of dementia, cancer, Alzheimer and immune diseases, thus driving the demand for clinical trials and research that requires cell separation products. Technological advancement is encouraging companies to innovate in microfluid cell isolation technology. Strategic collaboration and partnerships are recent trends that are boosting innovation and the development of microfluidics-based products.

The stem cell is an important cell therapy used in the development of regenerative medicine, employed in the replacement of organs or tissues than treating them. The number of biotechnology companies operating throughout the world is rising in developing countries. Pharmaceutical companies are bound to utilize cell isolation techniques to develop drugs and continue contributing to innovation. The stem cells need a substantially higher number of clinical trials, thus boosting the growth of the market. The advancement in the development of drugs and treatments like CAR-T through cell isolation techniques is expected to boost pharmaceutical and biotechnology companies. Thus, driving the Cell Isolation market revenue.

Cell Isolation Market Segment Insights

Cell Isolation Cell Type Insights

The Cell Isolation market segmentation, based on cell type, includes Human Cells and Animal Cells. The animal cells segment dominates the market, accounting for the largest market revenue. The rising emphasis of government, healthcare, and private companies on novel drug discoveries and development is a main factor fueling the growth of the segment. This involves the utilization of animal cells in order to examine the efficiency, the pharmacokinetics of new drug molecules, and the preliminary toxicity. Further, the human cells segment is expected to be the rapid growing segment throughout the forecast period due to rising applications of isolated human cells in biopharmaceutical development; research, and clinical trials are the major factors owing to the growing focus on human & cancer research.

Figure 1 Cell Isolation Market, by Cell Type, 2022 & 2032 (USD Billion)

Source the Secondary Research, Primary Research, MRFR Database, and Analyst Review

Cell Isolation Techniques Insights

The Cell Isolation market segmentation, based on techniques, includes Centrifugation, Surface Marker, and Filtration. The centrifugation segment dominates the market owing to the extensive use of this technique by research laboratories, academic institutes, and biotechnology and pharmaceutical companies. This technique is one of the most crucial steps in the process. Further, the surface marker segment is anticipated to witness significant growth throughout the forecast years owing to the growing investments in manufacturing infrastructure by companies, and product advancements are major factors boosting this segment's growth. The manufacturers are involved in the utilization of modern surfaced markers for production to make sure an improved quality of the end product.

Cell Isolation Regional Insights

By region, the study gives market insights into the North America, Europe, Asia-Pacific, and the Rest of the World. The North American Cell Isolation market area dominates the market owing to the availability of well-established biotech and pharmaceutical industries and the growing adoption of technologically advanced solutions in this region. The extensive research activities by research universities in the field of cell therapies have generated a huge demand for cell isolation solutions in the North American region.

Further, the prime countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil.

Figure 2 THE CELL ISOLATION MARKET SHARE BY REGION 2022 (USD Billion)

Source The Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe's Cell Isolation market accounts for the second-largest market share due to growing funding by the government for stem and cancer cell research and the growth of biopharmaceutical & biotechnology industries in this region. Further, the German Cell Isolation market held the largest market share, and the UK Cell Isolation market was the rapid-growing market in European region.

The Asia-Pacific Cell Isolation Market is expected to grow at the rapid CAGR from 2023 to 2032. This is due to the growing biotechnology & pharmaceutical industries in developing economies and, the growth in healthcare expenditure, and the rise in market penetration of main market players in this region. Moreover, China’s Cell Isolation market held the largest market share, and the Indian Cell Isolation market was the rapid-growing market in Asia-Pacific region.

Cell Isolation Key Market Players & Competitive Insights

Leading market players are investing hugely in research and development in order to expand their product lines, which will help the Cell Isolation market grow even more. Market players are also undertaking a variety of strategic activities to spread their  footprint, with important market developments including new product launches, higher investments, contractual agreements, mergers and acquisitions, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Cell Isolation industry must offer cost-effective items.

Manufacturing locally to minimize the operational costs is one of the key business tactics utilized by manufacturers in the  Cell Isolation industry to benefit clients and increase the market sector. In recent years, the Cell Isolation industry has offered some of the most significant advantages to biotechnology. Major players in the Cell Isolation market, including Thermo Fisher Scientific Inc., Akadeum Life Science Inc., Beckman Coulter, GE Healthcare, Becton Dickinson and Company, Bio-Rad Laboratories Inc, Danaher Corporation, STEMCELL Technologies Inc., PerkinElmer, Inc, Miltenyi Biotec, and others, are attempting to increase market demand by investing in the research and development operations.

Thermo Fisher Scientific Inc. was formed in the year 2006 through the merger of Fisher Scientific and Thermo Electron. The company is an American supplier of life sciences solutions, specialty diagnostics, analytical instruments, laboratory, biotechnology services, and pharmaceutical services. The company manufactures scientific instruments, consumables, and chemicals. The company operates through four segments analytical technologies, specialty diagnostic products, life science solutions, and lab products and services, which include CRO services. In October 2022, a closed and automated cell isolation and bead removal solution was launched by the company in order to help evolve cell therapy manufacturing. The new technology enhances cell purity and isolation efficiency and raises the recovery of target cells for scalable cell therapy manufacturing.

Akadeum Life Science Inc. is the developer of Bio-separation products to facilitate the target cell removal from biological samples. The company is an emerging life science startup located in Ann Arbor, MI, founded in the year 2014. The product of the company is based on buoyancy-activated cell sorting, which utilizes microscopic micro-bubbles to capture target cells and rapidly floats them to the surface of the liquid sample for removal, allowing medical practitioners to utilize those cells for performing downstream testing and analysis with higher efficiency. In May 2023, a new series of products, namely leukoplakia human immune cell isolation and T-cell activation/expansion kits for the research and development of cell therapy. This development will strengthen the Leukopak cell isolation product lines of the company.

Key Companies in the Cell Isolation market include

• Thermo Fisher Scientific Inc.


• Akadeum Life Science Inc.


• Beckman Coulter


• GE Healthcare


• Becton Dickinson and Company


• Bio-Rad Laboratories Inc


• Danaher Corporation


• STEMCELL Technologies Inc.


• PerkinElmer, Inc


• Miltenyi Biotec

Cell Isolation Industry Developments

August 2022 Beckman Coulter, a clinical diagnostics company, has launched ARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test showed 99.9% specificity against 1,400 negative samples and 983% sensitivity at 15-30 days post-symptom onset.

January 2022 Solace Nutrition, is a US-based medical nutrition company, which bought R-Kane Nutritionals' assets for an unknown sum. This asset acquisition allows Solace Nutrition to develop synergy between both the brands, accelerate growth, and create a position in an adjacent nutrition sector. R-Kane Nutritionals is a firm formed in the United States that specializes in high-protein meal replacement products for weight loss.

October 2020 GE Healthcare, with the assistance of a supply arrangement, is now able to sell Serena Bright in the US. The first contrast-improved guided biopsy product in the market, Serena Bright, will help patients and clinicians in the fight against breast cancer.

Cell Isolation Market Segmentation

Cell Isolation Cell Type Outlook

• Human Cells


• Animal Cells

Cell Isolation Techniques Outlook

• Centrifugation


• Surface Marker


• Filtration

Cell Isolation Regional Outlook

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America
  
  
  
  

Cell Isolation Report Scope

Report Attribute/Metric	Details
Market Size 2024	6.80 (USD Billion)
Market Size 2025	8.01 (USD Billion)
Market Size 2034	34.98 (USD Billion)
Compound Annual Growth Rate (CAGR)	17.80 % (2025 - 2034)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2034
Historical Data	2020 - 2024
Report Coverage	Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Cell Type, Techniques, and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The US, Canada, German, France, UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil
Key Companies Profiled	Thermo Fisher Scientific Inc., Akadeum Life Science Inc., Beckman Coulter, GE Healthcare, Becton Dickinson and Company, Bio-Rad Laboratories Inc, Danaher Corporation, STEMCELL Technologies Inc., PerkinElmer, Inc, Miltenyi Biotec
Key Market Opportunities	Increased opportunities in emerging markets.
Key Market Dynamics	Increased adoption of cell isolation techniques and rising cases of chronic diseases that require clinical trials.